| The find of COVID-19 vaccine: Challenges and opportunities M ElBagoury, MM Tolba, HA Nasser, A Jabbar, AM Elagouz, Y Aktham, ... Journal of infection and public health 14 (3), 389-416, 2021 | 77 | 2021 |
| Use of medicinal plants for respiratory diseases in Bahawalpur, Pakistan S Afzal, HI Ahmad, A Jabbar, MM Tolba, S AbouZid, N Irm, F Zulfiqar, ... BioMed Research International 2021, 2021 | 39 | 2021 |
| The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in … IL Shytaj, M Fares, L Gallucci, B Lucic, MM Tolba, L Zimmermann, ... Mbio 13 (2), e03705-21, 2022 | 28 | 2022 |
| The global impact of the first Coronavirus Disease 2019 (COVID-19) pandemic wave on vascular services VERN COVER study collaborative, RA Benson, S Nandhra medRxiv, 2020.07. 16.20153593, 2020 | 28 | 2020 |
| Epidemiology and antibiogram of common mastitis-causing bacteria in Beetal goats A Jabbar, MH Saleem, MZ Iqbal, M Qasim, M Ashraf, MM Tolba, ... Veterinary world 13 (12), 2596, 2020 | 18 | 2020 |
| Pros and cons of using green biotechnology to solve food insecurity and achieve sustainable development goals HA Nasser, M Mahmoud, MM Tolba, RA Radwan, NM Gabr, AA ElShamy, ... Euro-Mediterranean Journal for Environmental Integration 6, 1-19, 2021 | 10 | 2021 |
| AmpC β-lactamase variable expression in common multidrug-resistant nosocomial bacterial pathogens from a tertiary hospital in Cairo, Egypt AA El Shamy, Z Zakaria, MM Tolba, NS Eldin, AT Rabea, MM Tawfick, ... International Journal of Microbiology 2021, 2021 | 7 | 2021 |
| The Superiority of Bacillus megaterium over Escherichia coli as a Recombinant Bacterial Host for Hyaluronic Acid Production HTA Nasser, BJ Eikmanns, MM Tolba, M El-Azizi, K Abou-Aisha Microorganisms 10 (12), 2347, 2022 | 3 | 2022 |
| Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine RM Ghazy, E Elrewany, A Gebreal, R ElMakhzangy, N Fadl, EH Elbanna, ... Vaccines 11 (11), 1708, 2023 | 2 | 2023 |
| A promising RNA nanotechnology in clinical therapeutics: a future perspective narrative review MM Tolba, A Jabbar, S Afzal, M Mahmoud, F Zulfiqar, I El-Soudany, ... Future Science OA 9 (8), FSO883, 2023 | 2 | 2023 |
| Documenting the recovery of vascular services in European centres following the initial COVID-19 pandemic peak: results from a multicentre collaborative study MA Ruffino, S Chan, P Coughlin, A Awopetu, P Stather, T Lane, ... EJVES vascular forum 57, 28-34, 2022 | 2 | 2022 |
| Drug repurposing through virtual screening and in vitro validation identifies tigecycline as a novel putative HCV polymerase inhibitor M ElHefnawi, E Jo, MM Tolba, M Fares, J Yang, M Shahbaaz, ... Virology 570, 9-17, 2022 | 1 | 2022 |
| Behind the scene: surprises and snags of pseudogenes HI Ahmad, A Jabbar, M Imran, S Ahmed, T Majeed, MM Tolba, HA Nasser, ... Critical Reviews™ in Eukaryotic Gene Expression 31 (5), 2021 | 1 | 2021 |
| Psychological antecedents toward COVID-19 vaccination explain the high rates of vaccine rejection among the Libyan population 2 years after starting vaccination campaigns RM Ghazy, MM Tolba, MR Abdelmessih Saleeb, FSA Abdullah, S Yazbek, ... Journal of Public Health, 1-12, 2024 | | 2024 |
| An in silico integrative analysis of hepatocellular carcinoma omics databases shows the dual regulatory role of microRNAs either as tumor suppressors or as oncomirs ME Mahmoud M. Tolba, Bangli Soliman, Abdul Jabbar, Hebat'Allah Nasser medRxiv, 7-21, 2021 | | 2021 |
| The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication (preprint) IL Shytaj, M Fares, B Lucic, L Gallucci, MM Tolba, L Zimmermann, ... | | 2021 |
| Cobicistat synergizes with remdesevir to suppress SARS-CoV-2 replication in vitro IL Shytaj, MM Tolba, B Lucic, L Gallucci, M Fares, L Zimmermann, ... Topics in Antiviral Medicine, 139-140, 2021 | | 2021 |
